Cover
Vol. 10 No. 2 (2020)

Published: August 31, 2020

Pages: 75-90

Research Article

The Effect of BMI on Serum and Follicular Fluid Level of Kisspeptin in Infertile Women.

Ghada Alanssari 1 Mufeda A. Jwad Amal A. Mohammed
1High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al Nahrain University, Baghdad, Iraq.
History
  • Received: July 7, 2020
  • Accepted: July 30, 2020
  • Available Online: August 8, 2020
DOI

https://doi.org/10.28969/IJEIR.v10.i2.r5.20

Abstract

Kisspepetin is considered as a key regulator of reproduction, through its direct role in controlling the hypothalamic pituitary gonadal axis necessary for controlling the ovulatory process and indirectly by impacting glucose heamostasis and metabolism. We aimed to examin the correlation between body mass index and level of Kisspeptin in serum and follicular fluid. This study is a cross sectional study done on (80) infertile Iraqi patients aged (18-40 years) scheduled for fresh intracytoplasmic sperm injection cycle. This study is conducted in the High Institute for Infertility Diagnosis and Assisted Reproductive Technologies of Al-Naharin University, from September 2020 to May 2021. For each participant, the GnRH antagonist protocol was used to hyperstimulate the ovaries, and samples from serum and follicular fluid were obtained at day of oocytes retrieval for measuring Kisspeptin level using enzyme linked immunosorbent assay (ELIZA) technique. Serum and follicular fluid Kisspeptin were insignificantly increasing with the increase in the BMI (p value =0.406) (p value = 0.352) respectively. Serum and follicular kisspetin were positively and significantly correlated (r = 0.536, p value= 0.000). Serum and follicular fluid kisspeptin were numerically increasing with the body mass index of infertile women, although this increament is statically insignificant, serum kisspeptin can be used as a mirror image to follicular fluid kisspeptin as there was a statistical association between them in this study.

Keywords

References

  1. Trevisan CM, Montagna E, de Oliveira R, Christofolini DM, Barbosa CP, Crandall KA, Bianco B. Kisspeptin/GPR54 system: what do we know about its role in human reproduction? Cellular Physiology and Biochemistry. 2018 Oct.49 (4):1259-76. Doi.org/10.1159/000493406
  2. Hu KL, Chang HM, Zhao HC, Yu Y, Li R, Qiao J. Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentation. Hum Reprod Update. 2019 May 1;25 (3):326-343. Doi: 10.1093/humupd/dmy046.
  3. Hussain MA, Song WJ, Wolfe A. There is Kisspeptin - And Then There is Kisspeptin. Trends Endocrinol Metab. 2015 Oct;26 (10):564-572. Doi: 10.1016/j.tem.2015.07.008.
  4. Colledge WH. Kisspeptins and GnRH neuronal signalling. Trends Endocrinol Metab. 2009 Apr;20 (3):115-21. Doi: 10.1016/j.tem.2008.10.005.
  5. Hrabovszky E, Ciofi P, Vida B, Horvath MC, Keller E, Caraty A, Bloom SR, Ghatei MA, Dhillo WS, Liposits Z, Kallo I. The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci. 2010 Jun;31 (11):1984-98. Doi: 10.1111/j.1460-9568.2010.07239.x.
  6. Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014 Jul-Aug;20 (4):485-500. Doi: 10.1093/humupd/dmu009.
  7. Ikegami K, Goto T, Nakamura S, Watanabe Y, Sugimoto A, Majarune S, Horihata K, Nagae M, Tomikawa J, Imamura T, Sanbo M, Hirabayashi M, Inoue N, Maeda KI, Tsukamura H, Uenoyama Y. Conditional kisspeptin neuron-specific Kiss1 knockout with newly generated Kiss1-floxed and Kiss1- Cre mice replicates a hypogonadal phenotype of global Kiss1 knockout mice. J Reprod Dev. 2020 Aug 20;66 (4):359-367. Doi: 10.1262/jrd.2020-026.
  8. Tang R, Ding X, Zhu J. Kisspeptin and polycystic ovary syndrome. Frontiers in endocrinology. 2019 May 10; 10:298. Doi.org/10.3389/fendo.2019.00298
  9. Cao Y, Li Z, Jiang W, Ling Y, Kuang H. Reproductive functions of Kisspeptin/KISS1R Systems in the Periphery. Reprod Biol Endocrinol. 2019 Aug 9;17 (1):65. Doi: 10.1186/s12958-019-0511-x.
  10. Kołodziejski PA, Pruszyńska-Oszmałek E, Korek E, Sassek M, Szczepankiewicz D, Kaczmarek P, Nogowski L, Maćkowiak P, Nowak KW, Krauss H, Strowski MZ. Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women. Physiol Res. 2018 Mar 16;67 (1):45- 56. Doi: 10.33549/physiolres.933467.
  11. Mancini A, Currò D, Cipolla C, Barini A, Bruno C, Vergani E, Di Segni C, Guidi F, Nicolotti N, Silvestrini A, Meucci E, Valentini P, Rossodivita AN. Evaluation of Kisspeptin levels in prepubertal obese and overweight children: sexual dimorphism and modulation of antioxidant levels. Eur Rev Med Pharmacol Sci. 2021 Jan;25 (2):941-949. Doi: 10.26355/eurrev_202101_24663.
  12. Cockwell H, Wilkinson DA, Bouzayen R, Imran SA, Brown R, Wilkinson M. KISS1 expression in human female adipose tissue. Arch Gynecol Obstet. 2013 Jan;287 (1):143- 7. Doi: 10.1007/s00404-012-2514-0.
  13. Clarke H, Dhillo WS, Jayasena CN. Comprehensive Review on Kisspeptin and Its Role in Reproductive Disorders. Endocrinol Metab (Seoul). 2015 Jun;30 (2):124-41. Doi: 10.3803/EnM.2015.30.2.124.
  14. Sithinamsuwan K, Mahachoklertwattana P, Wankanit S, Chanprasertyothin S, Pongratanakul S, Khlairit P, Poomthavorn P. Serum Kisspeptin and Its Relation to Metabolic Parameters and Glucose Metabolism in Prepubertal and Pubertal Obese Children. Int J Endocrinol. 2020 Nov 10;2020:8826401. Doi: 10.1155/2020/8826401.
  15. Celik N, Aydin S, Ugur K, Yardim M, Acet M, Yavuzkir S, Sahin İ, Celik O. Patatin- like phospholipase domain containing 3-gene (adiponutrin), preptin, kisspeptin and amylin regulates oocyte developmental capacity in PCOS. Cell Mol Biol (Noisy-le-grand). 2018 Dec 31;64 (15):7-12.
  16. Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH, Lim SY, Yoo KH, Jung KS, Kim YK, Rhee CK. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017 Aug 21;12:2465-2475. Doi: 10.2147/COPD.S141295.
  17. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab. 2020 Aug 1;105 (8):e2695–709. Doi: 10.1210/clinem/dgaa285.
  18. Starosta A, Gordon CE, Hornstein MD. Predictive factors for intrauterine insemination outcomes: a review. Fertil Res Pract. 2020 Dec 11;6 (1):23. Doi: 10.1186/s40738-020-00092-1.
  19. Butler AE, Abouseif A, Dargham SR, Sathyapalan T, Atkin SL. Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations. Sci Rep. 2020 Nov 3;10 (1):18895. Doi: 10.1038/s41598-020-75109-2.
  20. Rashad NM, Al-Sayed RM, Yousef MS, Saraya YS. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction. Diabetes Metab Syndr. 2019 May-Jun;13 (3):2086-2092. Doi: 10.1016/j.dsx.2019.04.017.
  21. Ibrahim RO, Omer SH, Fattah CN. The Correlation between Hormonal Disturbance in PCOS Women and Serum Level of Kisspeptin. Int J Endocrinol. 2020 Jan 7;2020:6237141. Doi: 10.1155/2020/6237141.
  22. Rafique N, Latif R. Serum kisspeptin levels in normal and overweight Saudi females and its relation with anthropometric indices. Ann Saudi Med. 2015 Mar-Apr;35 (2):157-60. Doi: 10.5144/0256-4947.2015.157.
  23. Asalah, A., El-Sayed, M., Abdel-Aleem, D., EL Nagar, W., Gobran, A. Serum Kisspeptin Level in normal pregnancy and preeclampsia with and without obesity. Zagazig University Medical Journal, 2021; 27 (2): 343-351. Doi: 10.21608/zumj.2019.15804.1416